'Vaccinations to PrEPVacc trial participants have been stopped because an analysis of the data collected so far by our independent data-monitoring committee has led them to conclude that there is little or no chance of demonstrating that the vaccines we are testing are reducing the risk of acquiring HIV.'
'While we await the final results and analysis of individual products, I believe that our interim result puts this generation of putative HIV vaccines to bed,' said Prof Jonathan Weber, one of the trial's sponsors.
[
Collection
]
[
|
...
]